Hundreds of people with the most common type of cystic fibrosis could be offered a new triple therapy after the National Institute for Health and Care Excellence (NICE) recommended ...
Cystic fibrosis remains an incurable genetic disorder which impairs lung function and significantly reduces life expectancy. A new combination drug therapy which addresses the disorder's underlying ...
Please provide your email address to receive an email when new articles are posted on . A new study highlighted a decrease in pulmonary exacerbations during the COVID-19 pandemic among patients with ...
The mucus in the airways is not as sticky, inflammation in the lungs significantly reduced: Triple combination therapy can achieve these positive, lasting effects in patients with cystic fibrosis (CF) ...
Researchers conducted a phase 3b open-label trial at multiple sites in Australia and the European Union to assess the effect of elexacaftor-tezacaftor-ivacaftor, an approved medication for cystic ...
Cystic fibrosis is a hereditary disease that so far has been incurable. Those affected have thick, viscous mucus secretions in their lungs, and lung function diminishes steadily over time. Today, ...
(WNDU) - Cystic fibrosis is an inherited disease that affects the lungs, the pancreas, and other organs. There is no cure. New medications have come a long way to improve the symptoms for many, but ...
Enrollment has begun in an early-stage clinical trial evaluating bacteriophage therapy in adults with cystic fibrosis (CF) who carry Pseudomonas aeruginosa (P. aeruginosa) in their lungs. The trial is ...
Pharmaceutical Technology on MSN
JPM26: Vertex hopes to match cystic fibrosis success in pain and kidney disease
Vertex on track for “five launches in five disease areas over a five-year period” through emerging pain and renal franchises.
In patients with cystic fibrosis, CMTX-101, an immune-enabling antibody therapy, lowered four inflammatory biomarkers and ...
SPL84 is administered directly into the lungs where it is taken up by the cells and is expected to drive the production of fully functional CFTR proteins. The Food and Drug Administration (FDA) has ...
NEW HAVEN, Ct. - Deep breaths in and out are something many take for granted. For people with cystic fibrosis, the lungs fill with thick mucus, making it tough to get air. It also clogs the pancreas ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results